Inventor
PATEL NARENDRA KUMAR B
CA20 patents
⚠️ This page may combine multiple inventors who share the name “PATEL NARENDRA KUMAR B”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV HEALTH NETWORK
16 patentsUS9657025B2May 23, 2017
Pyrazolopyrimidine compounds
UNIV HEALTH NETWORK11 citations92
US9573954B2Feb 21, 2017
Pyrazolopyrimidine compounds
UNIV HEALTH NETWORK13 citations92
US9139563B2Sep 22, 2015
Kinase inhibitors and method of treating cancer
UNIV HEALTH NETWORK14 citations92
US10358436B2Jul 23, 2019
Kinase inhibitors and method of treating cancer
UNIV HEALTH NETWORK4 citations84
US9907800B2Mar 6, 2018
Kinase inhibitors and method of treating cancer
UNIV HEALTH NETWORK7 citations84
US8999968B2Apr 7, 2015
Kinase inhibitors and method of treating cancer with same
UNIV HEALTH NETWORK13 citations84
US10106545B2Oct 23, 2018
Pyrazolopyrimidine compounds
UNIV HEALTH NETWORK4 citations83
US9796703B2Oct 24, 2017
Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones
UNIV HEALTH NETWORK4 citations83
US9579327B2Feb 28, 2017
Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones
UNIV HEALTH NETWORK5 citations83
USRE47731ENov 19, 2019
Kinase inhibitors and method of treating cancer with same
UNIV HEALTH NETWORK4 citations73
US10167289B2Jan 1, 2019
Pyrazolopyrimidine compounds
UNIV HEALTH NETWORK2 citations73
US10570143B2Feb 25, 2020
Pyrazolopyrimidine compounds
UNIV HEALTH NETWORK2 citations72
US10501474B2Dec 10, 2019
HPK1 inhibitors and methods of using same
UNIV HEALTH NETWORK3 citations72
US10077255B2Sep 18, 2018
Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones
UNIV HEALTH NETWORK2 citations72
US11059832B2Jul 13, 2021
HPK1 inhibitors and methods of using same
UNIV HEALTH NETWORK0 citations62
US9580390B2Feb 28, 2017
Indazole compounds as kinase inhibitors and method of treating cancer with same
UNIV HEALTH NETWORK0 citations40